Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH

Original language	English
Journal	European Heart Journal
Volume	42
Issue number	Supp.1
DOIs	https://doi.org/10.1093/eurheartj/ehab724.3347
Publication status	Published - 01 Oct 2021

Access to Document

• 10.1093/eurheartj/ehab724.3347Licence: Unspecified

Student theses

• Gut bacterial metabolites in hepatic lipotoxicity and non-alcoholic fatty liver disease

  Kaluzny, S. (Author), Su, Q. (Supervisor) & Hardiman, G. (Supervisor), Jul 2023

  Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Su, Q., & Kaluzny, S. (2021). Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH. European Heart Journal, 42(Supp.1). https://doi.org/10.1093/eurheartj/ehab724.3347

Su, Q. ; Kaluzny, S. / Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH. In: European Heart Journal. 2021 ; Vol. 42, No. Supp.1.

@article{a6c3bc992b5344249435ab11f1a5e42e,

title = "Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH",

author = "Q. Su and S. Kaluzny",

year = "2021",

month = oct,

day = "1",

doi = "10.1093/eurheartj/ehab724.3347",

language = "English",

volume = "42",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Supp.1",

}

Su, Q & Kaluzny, S 2021, 'Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH', European Heart Journal, vol. 42, no. Supp.1. https://doi.org/10.1093/eurheartj/ehab724.3347

Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH. / Su, Q.; Kaluzny, S.
In: European Heart Journal, Vol. 42, No. Supp.1, 01.10.2021.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH

AU - Su, Q.

AU - Kaluzny, S.

PY - 2021/10/1

Y1 - 2021/10/1

U2 - 10.1093/eurheartj/ehab724.3347

DO - 10.1093/eurheartj/ehab724.3347

M3 - Meeting abstract

SN - 0195-668X

VL - 42

JO - European Heart Journal

JF - European Heart Journal

IS - Supp.1

ER -

Su Q, Kaluzny S. Proatherogenic gut-microbiome metabolite trimethylamine elicits a gut-liver circuit to regulate TMAO metabolism and atherosclerosis via mediation of CREBH. European Heart Journal. 2021 Oct 1;42(Supp.1). doi: 10.1093/eurheartj/ehab724.3347